Rallybio Corporation Common Stock (RLYB) Stock Price

RLYBStock

$16.81+275.22%52W

Market Cap$89.27M

P/E—

PEG Ratio—

Div yield—

Beta-0.67

RLYB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)176.41%

Price vs S&P 500 (4W)3.85%

VGM Score52.02

Book Value / Share (Quarterly)$9.50

P/TBV (Annual)0.54x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-5.21

Price vs S&P 500 (YTD)193.37%

Net Profit Margin (TTM)-911.07%

EPS (TTM)$-1.37

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-1.37

EPS (Annual)$-1.59

ROI (Annual)-15.49%

Cash / Share (Quarterly)$8.85

Revenue Growth QoQ (YoY)0.00%

ROA (Last FY)-14.42%

Revenue Growth TTM (YoY)1.18%

EBITD / Share (TTM)$-5.72

ROE (5Y Avg)-49.11%

Operating Margin (TTM)-3777.86%

Cash Flow / Share (Annual)$-5.64

P/B Ratio1.79x

P/B Ratio (Quarterly)0.94x

Net Income / Employee (Annual)$-641,300

EV / Revenue (TTM)56.84x

ROA (TTM)-13.28%

EPS Incl Extra (Annual)$-1.59

Current Ratio (Annual)14.50x

Quick Ratio (Quarterly)12.69x

3-Month Avg Trading Volume0.18M

52-Week Price Return275.22%

Revenue / Employee (TTM)$61,300

Tangible BV / Share (Quarterly)$3.27

P/S Ratio (Annual)104.97x

Asset Turnover (Annual)0.01x

52-Week High$17.57

EPS Excl Extra (Annual)$-1.59

26-Week Price Return188.34%

Quick Ratio (Annual)13.56x

13-Week Price Return15.77%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)12.92x

Enterprise Value$48.77M

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$61,300

Pretax Margin (Annual)-1046.39%

Cash / Share (Annual)$10.36

3-Month Return Std Dev37.61%

Net Income / Employee (TTM)$-558,400

ROE (Last FY)-15.49%

EPS Basic Excl Extra (Annual)$-1.59

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.37

ROI (TTM)-14.39%

P/S Ratio (TTM)104.97x

Revenue / Share (Annual)$0.15

Tangible BV / Share (Annual)$4.47

Price vs S&P 500 (52W)256.66%

Year-to-Date Return206.19%

5-Day Price Return0.06%

EPS Normalized (Annual)$-1.59

ROA (5Y Avg)-45.30%

Net Profit Margin (Annual)-1046.39%

Month-to-Date Return5.52%

Cash Flow / Share (TTM)$-1.80

EBITD / Share (Annual)$-6.01

Operating Margin (Annual)-3955.48%

ROI (5Y Avg)-49.11%

EPS Basic Excl Extra (TTM)$-1.37

P/TBV (Quarterly)0.75x

P/B Ratio (Annual)0.50x

Pretax Margin (TTM)-911.07%

Book Value / Share (Annual)$10.97

Price vs S&P 500 (13W)13.82%

Beta-0.67x

Revenue / Share (TTM)$0.15

ROE (TTM)-14.39%

52-Week Low$3.67

vGradeD

gGradeC

mGradeA

vgmGradeC

RLYB Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$1.28	-$0.85	+33.33%(+$0.43)
Q1 2026	May 13, 2026	-$1.20	-$1.46	-21.67%(-$0.26)
Q4 2025	Mar 16, 2026	-$1.24	-$1.52	-22.58%(-$0.28)
Q3 2025	Nov 6, 2025	-$1.56	$2.88	+284.62%(+$4.44)
Q2 2025	Aug 7, 2025	-$1.96	-$1.76	+10.20%(+$0.20)

RLYB Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.17

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
RLYBRallybio Corporation Common Stock	D	C	A	$16.81
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Rallybio Corporation Common Stock

Rallybio is a clinical-stage biotechnology company developing therapeutic candidates for severe, rare diseases driven by complement dysregulation and blood disorders. Its lead program, RLYB116, is a C5 inhibitor targeting immune platelet transfusion refractoriness and refractory antiphospholipid syndrome. The company's pipeline also includes RLYB332, a long-acting antibody in preclinical development for iron overload disorders.